PPIDT00169

Drug Information
NameParathyroid hormone
SequenceSVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPRDAGSQRPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ
DrugBank_IDDB05829
Typebiotech
IndicationFor use/treatment in osteoporosis.

Dosage Forms
Form Route Strength
Injection, powder, for solution Subcutaneous
100 MCG
Injection, powder, for solution Subcutaneous
100 ?g
Injection, powder, for solution Subcutaneous
25 MCG
Injection, powder, for solution Subcutaneous
25 ?g
Injection, powder, for solution Subcutaneous
50 MCG
Injection, powder, for solution Subcutaneous
50 ?g
Injection, powder, for solution Subcutaneous
75 ?g
Injection, powder, for solution Subcutaneous
75 MCG
Injection, powder, lyophilized, for solution Subcutaneous
100 ug/0.08mL
Injection, powder, lyophilized, for solution Subcutaneous
25 ug/0.08mL
Injection, powder, lyophilized, for solution Subcutaneous
50 ug/0.08mL
Injection, powder, lyophilized, for solution Subcutaneous
75 ug/0.08mL
Injection, powder, for solution Subcutaneous
Injection, powder, for solution Subcutaneous
100 ug
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target P49190 PTH2R Parathyroid hormone 2 receptor Homo sapiens activator Link
target Q03431 PTH1R Parathyroid hormone/parathyroid hormone-related peptide receptor Homo sapiens activator Link